3-methylquercetin has been researched along with Acute-Radiation-Syndrome* in 1 studies
1 other study(ies) available for 3-methylquercetin and Acute-Radiation-Syndrome
Article | Year |
---|---|
Isorhamnetin Promotes 53BP1 Recruitment through the Enhancement of ATM Phosphorylation and Protects Mice from Radiation Gastrointestinal Syndrome.
Flavonoids are a subclass of polyphenols which are attractive, due to possessing various physiological activities, including a radioprotective effect. Tumor suppressor p53 is a primary regulator in the radiation response and is involved in the pathogenesis of radiation injuries. In this study, we revealed that isorhamnetin inhibited radiation cell death, and investigated its action mechanism focusing on DNA damage response. Although isorhamnetin moderated p53 activity, it promoted phosphorylation of ataxia telangiectasia mutated (ATM) and enhanced 53BP1 recruitment in irradiated cells. The radioprotective effect of isorhamnetin was not observed in the presence of ATM inhibitor, indicating that its protective effect was dependent on ATM. Furthermore, isorhamnetin-treated mice survived gastrointestinal death caused by a lethal dose of abdominal irradiation. These findings suggested that isorhamnetin enhances the ATM-dependent DNA repair process, which is presumably associated with the suppressive effect against GI syndrome. Topics: Acute Radiation Syndrome; Animals; Ataxia Telangiectasia Mutated Proteins; Female; Hep G2 Cells; Humans; Intestinal Mucosa; Mice; Mice, Inbred ICR; Phosphorylation; Quercetin; Radiation-Protective Agents; Tumor Suppressor p53-Binding Protein 1 | 2021 |